Product image of Microgynon 30 (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Microgynon 30

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Microgynon 30 (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol, the active ingredient in Microgynon 30, is a combined oral contraceptive presented as a 30 µg/150 µg tablet for oral use. It works together with levonorgestrel to prevent pregnancy in women of reproductive age.

GNH India supplies Microgynon 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and offering reliable logistics for timely delivery.

Manufacturer / TM Owner

Bayer Sa Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Microgynon 30, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

  • Contraception: Prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.
  • Menstrual cycle regulation: Helps achieve more regular bleeding patterns and reduces heavy flow.
  • Dysmenorrhea relief: May lessen menstrual pain associated with ovulatory cycles.

How It Works

  • Microgynon 30 combines ethinylestradiol and levonorgestrel to suppress the hypothalamic‑pituitary‑gonadal axis, lowering the LH and FSH surge required for ovulation. The estrogen component stabilises the endometrium, while the progestogen thickens cervical mucus and induces endometrial changes that together prevent fertilisation and implantation.

Side Effects

Microgynon 30 may cause a range of adverse reactions. Most are mild and transient, but serious events can occur.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like.
  • Breast tenderness: discomfort or swelling of the breasts.
  • Irregular bleeding: spotting or breakthrough bleeding between periods.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in deep veins.
  • Pulmonary embolism: clot migration to the lungs.
  • Severe allergic reaction: hives, swelling, or anaphylaxis.

Precautions & Warnings

Before prescribing Microgynon 30, clinicians should consider several safety factors.

  • Assess thrombotic risk: evaluate personal or family history of clotting disorders.
  • Avoid smoking: especially in women older than 35 years.
  • Monitor blood pressure: hypertension may increase cardiovascular risk.
  • Consider liver function: hepatic disease can alter hormone metabolism.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Avoid Interactions

Microgynon 30 can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive effectiveness.
  • Rifampin and similar antibiotics: may lower hormone levels.
  • Protease inhibitor antiretrovirals (e.g., ritonavir): can increase hormone concentrations and side‑effect risk.

Moderate Interactions (Monitor Closely)

  • St. John’s wort: may decrease contraceptive efficacy.
  • Certain antifungals (e.g., ketoconazole): may raise hormone levels, requiring monitoring.

Frequently Asked Questions

Microgynon 30 is a combined oral contraceptive used to prevent pregnancy in women of reproductive age. It works by inhibiting ovulation, thickening cervical mucus, and altering the uterine lining to reduce the chance of fertilisation and implantation.

The ethinylestradiol component provides estrogenic activity that stabilises the endometrium, while levonorgestrel supplies progestogenic action that suppresses the hypothalamic‑pituitary‑gonadal axis, preventing the LH and FSH surge needed for ovulation. Together they also thicken cervical mucus and modify the uterine lining.

The dosing regimen for Microgynon 30 is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily at the same time for 21 consecutive days followed by a hormone‑free interval, but the exact schedule should be confirmed with the prescriber.

Microgynon 30 is classified as pregnancy category X, meaning it must not be used during pregnancy because it can cause harm to the fetus. It is generally not recommended while breastfeeding unless the benefits outweigh risks, and a healthcare provider should be consulted.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Microgynon 30 contains 30 µg ethinylestradiol and 150 µg levonorgestrel, a dose combination that offers reliable contraception with a balance of efficacy and tolerability. Compared with lower‑dose formulations, it may provide more consistent cycle control but could have a slightly higher incidence of estrogen‑related side effects.

Store Microgynon 30 tablets at ambient temperature below 25 °C, in the original blister pack, and protect them from moisture and direct sunlight. Do not refrigerate or freeze the tablets, and keep them out of reach of children.

Microgynon 30 is taken orally, usually with water, once each day at the same time. The tablet should be swallowed whole and not split, chewed, or crushed to ensure proper absorption.

Serious risks include venous thromboembolism such as deep vein thrombosis or pulmonary embolism, arterial events like stroke or myocardial infarction, and severe allergic reactions. Women with a history of clotting disorders, smoking, or certain cardiovascular conditions should be evaluated carefully before use.

Microgynon 30 is contraindicated in women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or are smokers aged 35 years or older. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT